Osaic Holdings
ARNA

Osaic Holdings’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Osaic Holdings’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,683
Closed -$157K – 7787
2021
Q4 		$157K Sell
1,683
-219
-12% -$14.4K ﹤0.01% 4184
2021
Q3 		$114K Buy
1,902
+28
+1% +$1.65K ﹤0.01% 4420
2021
Q2 		$129K Sell
1,874
-171
-8% -$11.1K ﹤0.01% 4260
2021
Q1 		$142K Sell
2,045
-654
-24% -$50.3K ﹤0.01% 4061
2020
Q4 		$208K Sell
2,699
-345
-11% -$25.9K ﹤0.01% 3451
2020
Q3 		$215K Buy
3,044
+178
+6% +$11.9K ﹤0.01% 3180
2020
Q2 		$179K Sell
2,866
-34
-1% -$1.87K ﹤0.01% 3230
2020
Q1 		$117K Buy
+2,900
New +$133K ﹤0.01% 3346

Osaic Holdings's ARNA Position: Q1 2022 in Review

Osaic Holdings sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 1,683 shares — an estimated $157K sold.

Osaic Holdings first reported a position in ARNA in Q1 2020 and held it in 8 quarters. The position peaked at $215K in Q3 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Osaic Holdings reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Osaic Holdings sold 1,683 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $157K.
  • Osaic Holdings first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 8 quarters.
  • Osaic Holdings's Arena Pharmaceuticals Inc position peaked at $215K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Osaic Holdings's 13F filing for Q1 2022, filed 4 May 2022.